“Shift towards Biodegradable Stents”
The surgical stents market is experiencing significant growth, driven by advancements in minimally invasive procedures and the increasing adoption of drug-eluting stents (DES). A prominent trend in this market is the shift towards biodegradable stents, which are designed to dissolve over time, eliminating the need for a second surgery. These stents, made from materials such as bioabsorbable polymers, offer a more sustainable solution, reducing long-term risks such as restenosis (re-narrowing of arteries) and minimizing complications. For instance, the Absorb BVS (biodegradable vascular scaffold) from Abbott represents a breakthrough in the field, offering an alternative to traditional metal stents. As these biodegradable stents dissolve, they leave the artery free of a foreign object, lowering the risk of future complications and improving patient outcomes. This trend reflects the broader shift toward safer, more effective, and patient-friendly surgical solutions, making biodegradable stents a key area of focus for market growth and innovation.
